Paper Details

  1. Home
  2. Paper Details

Safety of anti-tumor necrosis factor agents in psoriatic arthritis - an update.

Author: D'AngeloSalvatore, LeccesePietro, OlivieriIgnazio, PadulaAngela, PalazziCarlo

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

Medications that block tumor necrosis factor (TNF) have revolutionized treatment for rheumatoid arthritis and spondyloarthritides (SpAs). For psoriatic arthritis (PsA), these medications are much more effective than conventional treatments in addressing all aspects of the disease, including spine, joints, tendons, fingers, and skin lesions. Understanding their safety is crucial for doctors.
Paper Details　
Original Abstract of the Article :
Tumor necrosis factor (TNF) blockers have represented a real revolution in the treatment of rheumatoid arthritis and spondyloarthritides (SpAs). In the case of psoriatic arthritis (PsA), anti-TNF agents are much more effective than conventional disease modifying antirheumatic drugs on all manifestat...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1517/14740338.2014.857655

データ提供：米国国立医学図書館（NLM）

Tumor Necrosis Factor Blockers: A Revolution in Psoriatic Arthritis Treatment

The field of [rheumatology] has witnessed a revolution in the treatment of [psoriatic arthritis (PsA)] with the advent of tumor necrosis factor (TNF) blockers. This study provides an update on the safety profile of these medications, highlighting their effectiveness in managing various PsA manifestations, including axial involvement, peripheral arthritis, and skin lesions. Researchers emphasize the importance of a thorough understanding of the potential risks and benefits of these medications in clinical practice.

Navigating the Desert of Inflammation: TNF Blockers for Psoriatic Arthritis

This study underscores the importance of carefully considering the risks and benefits of TNF blockers in the treatment of PsA. It’s like a wise desert traveler preparing for a long journey; assessing the potential hazards and preparing for the challenges ahead is crucial for a successful and safe expedition.

A Balancing Act: Managing Psoriatic Arthritis with Precision

This research emphasizes the importance of a comprehensive understanding of the safety profile of TNF blockers. It's like navigating a shifting sand dune; a careful and strategic approach is needed to avoid potential risks and maximize the benefits.

Dr.Camel's Conclusion

This study provides valuable insights into the safety profile of TNF blockers in the treatment of PsA, highlighting their effectiveness and emphasizing the importance of individualized treatment approaches.

Date :
  1. Date Completed 2014-09-05
  2. Date Revised 2018-12-03
Further Info :

Pubmed ID

24219428

DOI: Digital Object Identifier

10.1517/14740338.2014.857655

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.